Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Inclusion Criteria: 1. Healthy men and women; 2. Age 18 to 60 years, inclusive; 3. Weight ≥ 50 kg and Body Mass Index (BMI) of 19 to 32, inclusive; 4. Female subjects must be of non-childbearing potential; 5. Male subjects must agree to use a double barrier method of birth control; 6. Signed informed consent form (ICF) prior to study procedures. Exclusion Criteria: 1. Current or recent (within 14 days of Day 0) bacterial or viral infection; 2. Positive results at screening for hepatitis B surface antigen, hepatitis C antibody, or HIV antibody; 3. Clinically significant abnormalities noted on ECG; 4. Safety laboratory abnormalities; 5. Regular use of medications, prescription or non-prescription; 6. Poor vein access or fear of venipuncture or sight of blood; 7. Major surgery, significant recent injury or trauma within 30 days; 8. Received an investigational drug or vaccine within 30 days.